Navigation Links
Beckman Coulter Announces the Creation of Beckman Coulter Genomics

BEVERLY, Mass., Aug. 12 /PRNewswire/ -- Beckman Coulter, Inc. (NYSE: BEC) today announced the creation of Beckman Coulter Genomics. The new company, which combines Agencourt Bioscience and the newly acquired Cogenics, offers researchers a single genomic services resource with expanded global capabilities.

"Through the creation of Beckman Coulter Genomics, we have successfully brought together the industry's leading genomic service providers to offer our customers the highest-quality data and analysis," said Richard Creager, Ph.D., Beckman Coulter group vice president of Immunoassay, Molecular Diagnostics and Genomic Services.

Genomic researchers dedicate months to collecting DNA and RNA samples. Before turning over precious samples for analysis, they need to be able to trust that their service provider understands the research goals and will deliver a successful outcome. From classic to cutting-edge, Beckman Coulter Genomics' team has expertise and experience on a wide range of genomic technology platforms and is dedicated to delivering the highest-quality results. Services currently available through Beckman Coulter Genomics include sequencing, sample preparation, genotyping, gene expression, biological efficiency and safety testing, with support for all levels of regulatory compliance, including Clinical Laboratory Improvement Amendments (CLIA). In addition, Beckman Coulter Genomics offers all three commercially available next-generation sequencing platforms: Roche 454 Genome Sequencer FLX with Titanium, Applied Biosystems SOLiD* and Illumina* Genome Analyzer.

"We understand that each customer, each sample and each study is unique and extremely important," said Susan Evans, Ph.D., general manager of Beckman Coulter Genomics. "That is why we strive to create a partnership with each customer through a consistent and personalized approach. Our experienced team has the energy and resolve needed to deliver high-quality results scientists can trust, on time and on budget."

Beckman Coulter Genomics has offices throughout North America and Europe. For more information about Beckman Coulter Genomics and its services please visit:, and For more information about Beckman Coulter, please visit

Beckman Coulter and the stylized logo are registered trademarks of Beckman Coulter, Inc.

*Trademarks are property of their respective owners.

About Beckman Coulter Genomics

Beckman Coulter Genomics, headquartered in Beverly, Massachusetts, is a leading provider of genomic services and nucleic acid purification products, serving life-science researchers and the pharmaceutical industry throughout the world. The company was created by combining Beckman Coulter's Agencourt Bioscience with the newly acquired Cogenics. By providing technical expertise, combined with personalized service, Beckman Coulter Genomics delivers the highest-quality data, robust analyses and innovative thinking. For more information, visit, or

About Beckman Coulter

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company's 2008 annual revenue of $3.1 billion. For more information, visit

Link to the news release at:

SOURCE Beckman Coulter Genomics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Upcoming Beckman Coulter Investor Events Second Half of 2009
2. Viles & Beckman, LLC: Stop Your Headache NOT Your Liver
3. Beckman Coulter to Present at the 2009 Goldman Sachs Healthcare Conference
4. Beckman Coulter, Inc. Announces Common Stock Offering
5. Beckman Coulter Pending Acquisition of Olympus Diagnostics Systems Passes Milestone with U.S. Regulatory Approval
6. Beckman Coulter Announces First in Series of Flow Cytometry Product Introductions for 2009
7. Beckman Coulter to Present at Upcoming Healthcare Conferences
8. Beckman Coulter Announces Third Quarter 2008 Results
9. Beckman Coulter to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. Beckman Coulter Announces First Quarter 2008 Earnings to be Released on Wednesday, April 30, 2008, Before Market Opens
11. Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... An ... way to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC ... and dispense prescription medications. In doing so, it could help to prevent potential ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed ... 1-1 ). More than 3.7 billion people under the age of 50 – or ... to WHO's first global estimates of HSV-1 infection . , "The data shocks us ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... innovative online platform for mental health and wellness consultation, has collaborated with a ... will bridge the knowledge gap experienced by parents and bring advice from parenting ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer ... incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product ... Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not only ...
(Date:11/26/2015)... ... November 26, 2015 , ... The ... bioavailability and the need to integrate dose form selection in early phase drug ... the membership organization supporting and bringing together the UK’s emerging life sciences companies, ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
Breaking Medicine Technology: